President and CEO Emil D Kakkis sold $1.4M of Ultragenyx Pharmaceutical Inc.

Sold$1,352,251

$67.61Price

20,000Shares

−1%Stake

What RARE did after the filing

Prices for RARE after this filing aren't in yet.

Traded Mon, Aug 15. Filed Wed, Aug 17, 4:12 PM ET, after the close. Not investment advice.